DSM and Sanquin sign manufacturing agreement for factor IX antibody

10/24/2013 | Genetic Engineering & Biotechnology News

Sanquin Blood Supply Foundation and DSM Pharmaceutical Products have signed a commercial manufacturing agreement to produce a monoclonal antibody for the recovery and purification of coagulation factor IX from human blood. Production will take place at a DSM Biologics facility in the Netherlands.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN